Abstract
In a prospective study of 52 consecutive women who required acceleration of labour intravenous prostaglandin E2 (PGE2) was used as the oxytocic agent. These mothers were matched for age, parity, height, gestational age, initial cervical dilatation, and station and position of the fetal head with 52 women whose labours were accelerated with oxytocin; both drugs were equally effective. Acceleration to delivery intervals, second-stage durations, the number of assisted deliveries, and Apgar scores were similar regardless of the oxytocic used. Although PGE2 compares well with oxytocin, it offers no further advantages and is more expensive and less well tried than oxytocin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beazley J. M., Kurjak A. Influence of a partograph on the active management of labour. Lancet. 1972 Aug 19;2(7773):348–351. doi: 10.1016/s0140-6736(72)91735-7. [DOI] [PubMed] [Google Scholar]
- Clegg D. R., Flynn A. M., Kelly J. A comparison of intravenous prostaglandin E2 and intravenous oxytocin for the augmentation of labour complicated by delay. J Obstet Gynaecol Br Commonw. 1974 Dec;81(12):995–999. doi: 10.1111/j.1471-0528.1974.tb00421.x. [DOI] [PubMed] [Google Scholar]
- O'Driscoll K., Jackson R. J., Gallagher J. T. Active management of labour and cephalopelvic disproportion. J Obstet Gynaecol Br Commonw. 1970 May;77(5):385–389. doi: 10.1111/j.1471-0528.1970.tb03539.x. [DOI] [PubMed] [Google Scholar]
- Studd J., Clegg D. R., Sanders R. R., Hughes A. O. Identification of high risk labours by labour nomogram. Br Med J. 1975 Jun 7;2(5970):545–547. doi: 10.1136/bmj.2.5970.545. [DOI] [PMC free article] [PubMed] [Google Scholar]